-

Ardent Health Appoints Dave Styblo to Lead Investor Relations

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent’s investor relations program and serve as the primary liaison with investors, analysts and financial partners.

Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jefferies for more than a decade as an equity research analyst with a focus on healthcare services and managed care stocks.

Most recently, Styblo served as an independent investor relations advisor to healthcare companies. He began his career as a sell-side research associate at JPMorgan Chase/Bear Stearns & Co. Styblo is a graduate of the University of Virginia.

“Dave’s deep experience and industry knowledge will be a great asset as we continue to build strong relationships and share the Ardent story across the investment community,” said Ardent Health Chief Financial Officer Alfred Lumsdaine. “We are excited to welcome him to Ardent as we begin this new chapter as a public company.”

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 affiliated providers across six states. For more information, please visit www.ardenthealth.com.

Contacts

Investor Contact:
Dave Styblo
Investor.Relations@ardenthealth.com
(615) 296-3016

Media Contact:
Rebecca Kirkham
rebecca.kirkham@ardenthealth.com
(615) 296-3635

Ardent Health

NYSE:ARDT

Release Versions

Contacts

Investor Contact:
Dave Styblo
Investor.Relations@ardenthealth.com
(615) 296-3016

Media Contact:
Rebecca Kirkham
rebecca.kirkham@ardenthealth.com
(615) 296-3635

More News From Ardent Health

Ardent Health and hellocare.ai Partner to Implement Enterprise AI Assisted Virtual Physician, Nursing, Patient Safety and Intelligent Care Delivery

BRENTWOOD, Tenn. & CLEARWATER, Fla.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has partnered with hellocare.ai as its enterprise platform for AI assisted virtual physician, virtual nursing, virtual patient observation and advanced patient safety capabilities. The deployment will span more than 2,000 patient rooms and support a broad range of inpatient care environments. Through this pa...

Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company’s financial results and conduct a question-and-answer session. A webcast of the conference call and ac...

Ardent Health Announces $50 Million Share Repurchase Program Authorization

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced its Board of Directors has authorized a share repurchase program of up to $50 million. “This authorization reflects our conviction in the fundamental strength of Ardent’s business and our ability to deliver sustained, long-term shareholder value,” said Marty Bonick, President and Chief Executive Officer. “With a strong balance sh...
Back to Newsroom